KineMed, Inc.’s Study of Merck & Co., Inc.’s Ezetimibe (ZETIA(R)) Invited to Join Best of American Heart Association Specialty Conference Poster Session

EMERYVILLE, Calif.--(BUSINESS WIRE)--The American Heart Association (AHA) has honored KineMed’s abstract entitled “Ezetimibe Treatment Stimulates Transport of Plasma Cholesterol into Fecal Neutral Sterols in Hyperlipidemic Humans” with a position in the Best of AHA Specialty Conference Poster Session that will take place at the AHA Chicago meeting November 13-17, 2010. The study was performed in partnership with the University of California Berkeley, Radiant Research, Chicago Pritzker School of Medicine, and Merck/Schering Plough.